Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ray Coquard, I.L.
575  Ergebnisse:
Personensuche X
?
1

19P Long term sexual disorders among rare ovarian cancer su..:

Dubot, C. ; Joly Lobbedez, F. ; Ray Coquard, I.L....
ESMO Open.  8 (2023)  1 - p. 101040 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Economic Impact of Centralized Histological Reviews in Pati..:

Perrier, L. ; Kembou, Nzale S. ; Rascle, P....
Value in Health.  17 (2014)  7 - p. A624 , 2014
Link: https://doi.org/10.1016/..
 
?
3

PRM143 Cluster Analysis and Principal Component Analysis to..:

Perrier, L. ; Buja, A. ; Mastrangelo, G....
Value in Health.  15 (2012)  7 - p. A486 , 2012
Link: https://doi.org/10.1016/..
 
?
4

CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumo..:

Perrier, L. ; Ranchr̀e Vince, D. ; Terrier, P....
Value in Health.  15 (2012)  7 - p. A285 , 2012
Link: https://doi.org/10.1016/..
 
?
5

8003 ORAL Experience With Bevacizumab in the Management of ..:

Dubot, C. ; Emile, G.A. ; Lhomme, C....
European Journal of Cancer.  47 (2011)  - p. S528 , 2011
Link: https://doi.org/10.1016/..
 
?
6

Développement et validation d'un modèle pronostic pour préd..:

Sève, P. ; Devos, P. ; Adenis, A....
La Revue de Médecine Interne.  29 (2008)  - p. S315 , 2008
Link: https://doi.org/10.1016/..
 
?
7

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open.  9 (2024)  - p. 102442 , 2024
Link: https://doi.org/10.1016/..
 
?
8

82MO European multi-disciplinary tumor boards within the EU..:

Bergamini, A. ; Joneborg, U. ; Marquina, G....
ESMO Open.  9 (2024)  - p. 103542 , 2024
Link: https://doi.org/10.1016/..
 
?
9

34O ROCSAN: A multicentric randomized phase II/III evaluati..:

Ray-Coquard, I.L. ; Bellesoeur, A. ; Fabbro, M....
ESMO Open.  9 (2024)  - p. 103534 , 2024
Link: https://doi.org/10.1016/..
 
?
10

19P Long-term fatigue after treatments for non-epithelial o..:

Dubot, C. ; Ray-Coquard, I.L. ; Pautier, P....
ESMO Open.  9 (2024)  - p. 102558 , 2024
Link: https://doi.org/10.1016/..
 
?
11

VP3-2024: A randomized study of 6 vs 3 years of adjuvant im..:

Le Cesne, A. ; Schiffler, C. ; Bouche, O....
Annals of Oncology.  35 (2024)  6 - p. 576-577 , 2024
Link: https://doi.org/10.1016/..
 
?
12

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvan..:

Le Cesne, A. ; Chabaud, S. ; Bouche, O....
ESMO Open.  9 (2024)  - p. 102445 , 2024
Link: https://doi.org/10.1016/..
 
?
13

46MO What are the predictors of the success of interval deb..:

Marchetti, C. ; Colomban, O. ; Fagotti, A....
ESMO Open.  9 (2024)  - p. 103553 , 2024
Link: https://doi.org/10.1016/..
 
?
14

53P Description of BRCA mutated high-grade ovarian cancer d..:

Leary, A. ; Fouquier, A. ; Ray-Coquard, I.L....
ESMO Open.  9 (2024)  - p. 103560 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology.  35 (2024)  4 - p. 351-363 , 2024
Link: https://doi.org/10.1016/..
 
1-15